XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
shares in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)        
Revenues $ 49,895,000 $ 40,923,000 $ 147,586,000 $ 128,227,000
Cost of goods sold 54,680,000 40,152,000 152,333,000 113,830,000
Gross profit (loss) (4,785,000) 771,000 (4,747,000) 14,397,000
Research and development expenses 22,000 37,000 66,000 175,000
Selling, general and administrative expenses 5,087,000 4,563,000 16,222,000 12,548,000
Operating income (loss) (9,894,000) (3,829,000) (21,035,000) 1,674,000
Interest expense        
Interest rate expense 4,408,000 5,796,000 14,902,000 16,956,000
Debt related fees and amortization expense 1,140,000 674,000 3,045,000 2,578,000
Accretion and other expenses of Series A preferred units 2,185,000 1,765,000 7,928,000 4,087,000
Gain on debt extinguishment 0 0 (1,134,000) 0
Other expense (income) (30,000) 153,000 483,000 393,000
Loss before income taxes (17,597,000) (12,217,000) (46,259,000) (22,340,000)
Income tax expense (benefit) 0 0 7,000 (263,000)
Net loss (17,597,000) (12,217,000) (46,266,000) (22,077,000)
Other comprehensive (loss)        
Foreign currency translation gain (loss) 22,000 314,000 (187,000) (381,000)
Comprehensive loss $ (17,575,000) $ (11,903,000) $ (46,453,000) $ (22,458,000)
Net loss per common share        
Basic $ (0.55) $ (0.59) $ (1.55) $ (1.06)
Diluted $ (0.55) $ (0.59) $ (1.55) $ (1.06)
Weighted average shares outstanding        
Basic 31,857 20,861 29,818 20,732
Diluted 31,857 20,861 29,818 20,732